The targeting of the transcription factor pre-B-cell leukemia homeobox 3 (PBX3) by miR-98 further emphasized its importance in controlling GBM invasion, suggesting that the overexpression of miR-98 might be a potential therapeutic strategy to modulate PBX3 [97]. The gene discussed is PBX3; the disease is glioblastoma.